https://www.selleckchem.com/pr....oducts/gilteritinib-
Little is known about the safety and effectiveness of pharmacological cardioversion of recent-onset atrial fibrillation (AF) in the elderly. Antazoline has already been shown to be effective and safe in a wide variety of patients. To compare clinical effectiveness and safety of iv antazoline administered for pharmacological cardioversion of recent-onset AF in patients aged ≥75 years and younger. This retrospective analysis was conducted using data derived from emergency room medical records of patients qualified for pharmac
Curtir
Comentario
Compartilhar
